Ascenta Therapeutics
Manufacturing · 51-200 Employees
View Company Info for Free
Overview
Phone Number
(610) 408-0301Website
www.ascenta.comRevenue
$14.1 MillionIndustry
About Ascenta Therapeutics
Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis). Locust Walk Partners served as exclusive transaction advisor to Ascenta Therapeutics and Reed Smith LLP served as its legal counsel.Explore more
SIC Code 28,283NAICS Code 32,325Show moreAscenta Therapeutics Org Chart
Compare Similar Companies to Ascenta Therapeutics
Compare insights from companies similar to Ascenta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ascenta Therapeutics
$14.1M
51-200
Private
-
2003
JB
Jeffrey BrillAssociate Director, Clinical Development
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ascenta Therapeutics
Sign Up For FreeTo access detailed company insights
Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis). Locust Walk Partne... Read More